SILVER SPRING, Md. -- The FDA approved an expanded indication for the targeted cancer drug sorafenib (Nexavar) to treat metastatic, differentiated thyroid cancer.
Showing posts with label nexavar. Show all posts
Showing posts with label nexavar. Show all posts
Saturday, November 23, 2013
Nexavar OK'd for Thyroid Cancer
SILVER SPRING, Md. -- The FDA approved an expanded indication for the targeted cancer drug sorafenib (Nexavar) to treat metastatic, differentiated thyroid cancer.
Subscribe to:
Posts (Atom)